help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sexton, P. M.
Right arrow Articles by Findlay, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sexton, P. M.
Right arrow Articles by Findlay, D. M.

Endocrinology, Vol 134, 2103-2107, Copyright © 1994 by Endocrine Society

ARTICLES

Amylin is an agonist of the renal porcine calcitonin receptor

PM Sexton, S Houssami, CL Brady, DE Myers and DM Findlay
St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.

The cloned renal porcine calcitonin (pCT) receptor cDNA expressed by transient transfection in COS-1 cells or stable transfection in HEK-293 cells was assayed for interaction with CT, amylin, and CT gene-related peptide. Both [125I]salmon CT ([125I]sCT) and [125I]rat amylin displayed specific binding to transfected cells, and in both cases, pCT and rat amylin were equipotent in competing for binding. sCT was most potent in binding competition assays, whereas human CT and rat or human CT gene-related peptide did not compete. Despite the greater apparent affinity of sCT for receptor binding, sCT, pCT, and rat amylin had similar efficacies in stimulating the production of cAMP in the stably transfected cell line (EC50, 0.5-1.6 x 10(-9) M). These results contrasted with those obtained with the rat C1a CT receptor, for which amylin did not compete for [125I]sCT binding and stimulated cAMP production only at high concentrations. These results show that pCT and amylin interact with similar potencies with the pCT receptor and suggest that amylin may act as a natural ligand for this receptor.


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
G. Christopoulos, K. J. Perry, M. Morfis, N. Tilakaratne, Y. Gao, N. J. Fraser, M. J. Main, S. M. Foord, and P. M. Sexton
Multiple Amylin Receptors Arise from Receptor Activity-Modifying Protein Interaction with the Calcitonin Receptor Gene Product
Mol. Pharmacol., July 1, 1999; 56(1): 235 - 242.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
K. J. Perry, M. Quiza, D. E. Myers, M. Morfis, G. Christopoulos, and P. M. Sexton
Characterization of Amylin and Calcitonin Receptor Binding in the Mouse {alpha}-Thyroid-Stimulating Hormone Thyrotroph Cell Line
Endocrinology, August 1, 1997; 138(8): 3486 - 3496.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Quiza, M. Dowton, K. J. Perry, and P. M. Sexton
Electrophoretic Mobility and Glycosylation Characteristics of Heterogeneously Expressed Calcitonin Receptors
Endocrinology, February 1, 1997; 138(2): 530 - 539.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society